Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Byetta in obese/pre-diabetic young adults
NCT00845559Phase 4Withdrawn
- Sponsor
- Yale University
- Start
- Aug 2008
- Primary completion
- Mar 2010
01
Overview
A Phase 4 trial of exenatide in impaired glucose tolerance (IGT), sponsored by Yale University. Planned start Aug 2008; status: withdrawn.
02
Drugs
exenatide
03
Conditions
impaired glucose tolerance (IGT)
Beyond the preview
Go deeper on NCT00845559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00845559.